4:
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.
Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19. Summary for patients in: Ann Intern Med. 2007 Apr 17;146(8):I12.
PMID: 17310045 [PubMed - indexed for MEDLINE]
Related Articles
5:
Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.
Clin Ther. 2007 Feb;29(2):261-78.
PMID: 17472819 [PubMed - indexed for MEDLINE]
Related Articles
13:
The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS.
Chest. 2007 Dec;132(6):1756-63. Epub 2007 Oct 20.
PMID: 17951625 [PubMed - indexed for MEDLINE]
Related Articles